Nurse Practitioner in Garrison, ND Accepting Medicare
3 Nurse Practitioner nurses found. Showing 1 - 3
 Hedi J Rime, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 131 N. Main St, Garrison, ND 58540 Phone: 701-463-2626 Fax: 701-463-2501 |
 Mrs. Jacquelyn A Liffrig, RN, BSN, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 437 3rd Ave Se, Garrison, ND 58540 Phone: 701-463-2245 Fax: 701-463-6543 |
Forrest Leroy Hirsch, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 437 3rd Ave Se, Garrison, ND 58540 Phone: 701-463-2245 Fax: 701-463-6543 |
News Archive
Can a single BNT162b2 vaccine dose confer protective immunity against SARS-CoV-2 variants?
A team of researchers in Germany aimed to determine if the Pfizer-BioNTech vaccine mRNA vaccine (also known as the BNT162b2 vaccine) induces robust antibody responses against emergent SARS-CoV-2 variants, including the United Kingdom (or B1.1.7) variant; the South African (or B.1.351) variant; and the Brazilian (or P.1) variant.
Sysmex announces 3-year sole source microscopic urinalysis contract agreement with Novation
Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced a three-year sole source microscopic urinalysis contract agreement with group purchasing organization Novation. Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances, and 5,500 members of Provista, LLC, representing 28,000 sites.
Baylor Sammons Cancer Center, Sarah Cannon, and Virginia Cancer join Multiple Myeloma Research Consortium
The Multiple Myeloma Research Consortium (MMRC) today announced that it has expanded its clinical research network to include Baylor Charles A. Sammons Cancer Center (Dallas, TX), Sarah Cannon /Research Institute (SCRI, Nashville, TN) and Virginia Cancer Specialists (Fairfax, VA). These new centers join the 13 existing MMRC Member Institutions in promoting and facilitating collaborative research and accelerating drug development in multiple myeloma, an incurable blood cancer.
Low risk prostate cancer not always low risk
More and more men who believe they have low-risk prostate cancers are opting for active surveillance, forgoing treatment and monitoring the cancer closely with prostate-specific antigen (PSA) tests, digital rectal exams and ultrasounds at regular intervals to see if their tumors are growing. Nearly 400 men are now enrolled in the UCLA Active Surveillance program, the largest in Southern California.
Cetylpyridinium chloride-containing mouthwashes shown to inhibit SARS-CoV-2 in oral cavity
A team of international scientists has recently demonstrated the usefulness of cetylpyridinium chloride-containing mouthwashes in inhibiting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and reducing the risk of viral transmission. The study is currently available on the bioRxiv* preprint server.
› Verified 5 days ago